The Characteristics, Treatment Patterns and Prognosis of Chinese Male Breast Cancer: A Real-world Study
NCT06220630 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1200
Last updated 2024-01-24
Summary
The goal of this observational study is to investigate the features in Chinese male breast cancer (MBC) patients. The main question it aims to answer is:
* The characteristics, treatment patterns and prognosis of Chinese MBC patients. The clinicopathological characteristics, treatment information and follow-up data of participants will be extracted from a Chinese national database (Chinese Society of Clinical Oncology Breast Cancer database) and other involved Chinese centers.
Researchers will investigate the features, survival associated factors and other relevant factors of this population.
Conditions
Interventions
- OTHER
-
Male patients who were microscopically diagnosed as primary breast cancer.
Sponsors & Collaborators
-
Beijing Medical Award Foundation
collaborator UNKNOWN -
The Affiliated Cancer Hospital of Xinjiang Medical University
collaborator UNKNOWN -
Hebei Medical University Fourth Hospital
collaborator OTHER -
The Third Affiliated Hospital of Kunming Medical University
collaborator UNKNOWN -
Sun Yat-sen University
collaborator OTHER -
The Affiliated Cancer Hospital of Zhengzhou University
collaborator UNKNOWN -
The Third Hospital of Nanchang City
collaborator UNKNOWN -
Beijing 302 Hospital
collaborator OTHER -
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
collaborator OTHER -
Fujian Provincial Hospital
collaborator OTHER -
First Hospital of China Medical University
collaborator OTHER -
The Affiliated Hospital of Qingdao University
collaborator OTHER -
Guangdong Provincial People's Hospital
collaborator OTHER -
First Affiliated Hospital Xi'an Jiaotong University
collaborator OTHER -
First People's Hospital of Foshan
collaborator OTHER -
Peking University First Hospital
collaborator OTHER -
The Affiliated Hospital Of Guizhou Medical University
collaborator OTHER -
Guangdong Provincial Hospital of Traditional Chinese Medicine
collaborator OTHER -
Jiangmen Central Hospital
collaborator OTHER -
The Second Affiliated Hospital, Guangzhou Medical University
collaborator UNKNOWN -
The First Affiliated Hospital, Zhejiang University
collaborator UNKNOWN -
Peking University Shenzhen Hospital
collaborator OTHER -
The Second Affiliated Hospital of Harbin Medical University
collaborator OTHER -
Affiliated Sanming First Hospital of Fujian Medical University
collaborator UNKNOWN -
Jieyang People's Hospital
collaborator OTHER -
National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital
collaborator UNKNOWN -
Shantou Central Hospital
collaborator OTHER -
The First Affiliated Hospital with Nanjing Medical University
collaborator OTHER -
Lianjiang Pepole's Hospital, Lianjiang
collaborator UNKNOWN -
Guangdong Women and Children Hospital
collaborator OTHER -
Zhanjiang Central Hospital
collaborator UNKNOWN -
Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine
collaborator UNKNOWN -
First Affiliated Hospital, Sun Yat-Sen University
lead OTHER
Principal Investigators
-
Ying Lin, MD, PhD · 1st affiliated hospital of Sun Yat-sen university
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-08-01
- Primary Completion
- 2025-08-01
- Completion
- 2025-12-31
Countries
- China
Study Locations
More Related Trials
-
The Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy.
NCT06019455 ·Status: RECRUITING
-
Efficacy and Safety of Microwave Ablation Combined With Camrelizumab and Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer: a Multicenter, Open, Prospective Study
NCT05532527 ·Status: UNKNOWN ·Phase: NA
-
A Real-world Study on the Treatment of Non-small Cell Lung Cancer With Leptomeningeal Metastasis in China
NCT06718972 ·Status: RECRUITING
-
Clinical Study on the Prevention of Driver Gene Negative Ib-IIIb Lung Cancer Recurrence and Metastasis by Staged Chinese Herbal Medicine Combined With Chemotherapy and Immune Checkpoint Inhibitors
NCT05834413 ·Status: RECRUITING ·Phase: NA
-
Efficacy Study of Clinical Nutrition to Treat Lung Neoplasms And Breast Carcinoma
NCT02603016 ·Status: COMPLETED ·Phase: NA
-
Chinese Research Group of Gallbladder Cancer
NCT04140552 ·Status: RECRUITING
-
Long-term Follow-up of Anxiety and Depression in Patients With Malignant Tumors
NCT05596344 ·Status: RECRUITING
-
Bioinformation Therapy for Lung Cancer
NCT03239171 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Development and Prospective Validation of a Digital Pathology-based Artificial Intelligence Diagnostic Model for Pan-cancer Lymphatic Metastasis
NCT06517979 ·Status: RECRUITING
-
A Real-World Study of Treatment Patterns and Effectiveness in MET Mutation-Positive Advanced Lung Cancer
NCT06183762 ·Status: RECRUITING
-
Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization Associated With Chinese Patients With Advanced Lung Cancer
NCT03505515 ·Status: COMPLETED
-
MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC
NCT06198868 ·Status: RECRUITING
-
Interventional Ablation for Early-stage Lung Cancer
NCT07005999 ·Status: ACTIVE_NOT_RECRUITING
-
Prospective Study for Prognostic Biomarkers of Nasopharyngeal Carcinoma
NCT03025854 ·Status: UNKNOWN
-
Epidemiologic, Laboratory, and Clinical Characterization of Individuals With Cancer.
NCT00251563 ·Status: UNKNOWN
-
A Study of Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatments
NCT06617390 ·Status: COMPLETED
-
To Evaluate the Correlation Between the Results of Specific Gene Testing and the Efficacy of Targeted Therapy in Patients With NSCLC
NCT05805267 ·Status: COMPLETED
-
Prospective Real-World Study of Multimodal AI
NCT07269236 ·Status: ENROLLING_BY_INVITATION
-
Multimodal Large Model-Driven Risk and Prognosis Assessment for Brain Metastases in Lung Cancer
NCT07107035 ·Status: NOT_YET_RECRUITING
-
10-year Retrospective Study of Oral and Maxillofacial Squamous Cell Carcinoma
NCT06366906 ·Status: COMPLETED
-
Correlation Study of Lipid Metabolites as Markers of Hepatocellular Carcinoma
NCT06623474 ·Status: RECRUITING
-
A Real-world Study to Explore Recurrence/Metastases of the NSCLC Patients and the Impact Factors of Patient Survivals
NCT03710616 ·Status: UNKNOWN
-
AI-Based Multimodal Multi-tasks Analysis Reveals Tumor Molecular Heterogeneity, Predicts Preoperative Lymph Node Metastasis and Prognosis in Papillary Thyroid Carcinoma
NCT06241092 ·Status: RECRUITING
-
ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS
NCT03172156 ·Status: COMPLETED
-
Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan
NCT06358222 ·Status: RECRUITING